BupropiDex
NDC 71598-200, DEXTROMETHORPHAN HYDROBROMIDE, tablet, from DXM Pharmacuetical, Inc..
- Product NDC
- 71598-200
- Status
- Listed
- Labeler
- DXM Pharmacuetical, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M013
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71598-200 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEXTROMETHORPHAN HYDROBROMIDE15 mg/1
Pharmacologic classes
Sigma-1 Agonist [EPC]; Sigma-1 Receptor Agonists [MoA]; Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]; Uncompetitive NMDA Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71598-200-15 | 71598020015 | 200 TABLET in 1 BOTTLE (71598-200-15) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 71598-200 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71598-200 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71598-200. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.